BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3832755)

  • 1. Elevated progesterone levels in serum and ovarian venous blood in patients with ovarian tumors.
    Heinonen PK; Koivula T; Pystynen P
    Acta Obstet Gynecol Scand; 1985; 64(8):649-52. PubMed ID: 3832755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal activity of epithelial ovarian tumours in post-menopausal women.
    Heinonen PK; Mörsky P; Aine R; Koivula T; Pystynen P
    Maturitas; 1988 Mar; 9(4):325-38. PubMed ID: 3380017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral and ovarian venous concentrations of estradiol and progesterone in postmenopausal women with "non-endocrine" ovarian tumors.
    Kitayama S; Nakano R
    Acta Obstet Gynecol Scand; 1990; 69(3):245-8. PubMed ID: 2220347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protein fractions of benign and malignant cystomas].
    Mettler L; Mäder C
    Z Geburtshilfe Gynakol; 1971; 174(1):58-74. PubMed ID: 5554805
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral and ovarian venous concentrations of gonadal steroids and CEA in women with ovarian tumors.
    Jeppsson S; Kullander S; Rannevik G
    Acta Obstet Gynecol Scand; 1982; 61(3):209-12. PubMed ID: 6812383
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated serum progesterone levels in postmenopausal women with mucinous ovarian tumors.
    Matsuoka A; Tate S; Nishikimi K; Ishikawa H; Shozu M
    Menopause; 2016 May; 23(5):544-9. PubMed ID: 26926326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in insulin-like growth factor I, 17-b-estradiol, and progesterone in postmenopausal women with benign and malignant ovarian tumours.
    Waksmański B; Dudkiewicz J; Kowalski T
    Med Sci Monit; 2001; 7(5):919-23. PubMed ID: 11535935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral and ovarian venous concentrations of steroid and gonadotropin hormones in postmenopausal women with epithelial ovarian tumors.
    Heinonen PK; Koivula T; Rajaniemi H; Pystynen P
    Gynecol Oncol; 1986 Sep; 25(1):1-10. PubMed ID: 3732908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
    Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
    N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma androstenedione and oestrone levels before and after the menopause. II. Non-endocrine ovarian tumours and cysts.
    Mango D; Scirpa P; Battaglia F; Scirpa S; Montemurro A
    Maturitas; 1982 Apr; 4(1):43-8. PubMed ID: 7099002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor in ovarian cyst fluid.
    Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; Boonstra H; Sweep CG
    Cancer; 2001 Jan; 91(2):371-7. PubMed ID: 11180084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
    Harłozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R
    Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medium-weight molecules in the blood serum of patients with hyperplastic processes in the endometrium and benign and malignant ovarian tumors].
    Nikolaenkova VA; Alenina TV; Sterliagova LI
    Akush Ginekol (Mosk); 1991 Oct; (10):56-8. PubMed ID: 1789328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen production by epithelial ovarian tumours in post-menopausal women.
    Heinonen PK
    Maturitas; 1991 Jun; 13(2):117-22. PubMed ID: 1921734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total inhibin is a potential serum marker for epithelial ovarian cancer.
    Tsigkou A; Marrelli D; Reis FM; Luisi S; Silva-Filho AL; Roviello F; Triginelli SA; Petraglia F
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2526-31. PubMed ID: 17473066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum level of dehydroepiandrosterone sulfate in postmenopausal women with ovarian cancer.
    Heinonen PK; Koivula T; Pystynen P
    Gynecol Obstet Invest; 1987; 23(4):271-4. PubMed ID: 2956173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of serum acute-phase reactants in patients with ovarian tumors.
    Warwas M; Dobryszycka W; Gerber J; Pietkiewicz A
    Neoplasma; 1981; 28(4):485-90. PubMed ID: 7290269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pattern of estradiol and progesterone differs in serum and tissue of benign and malignant ovarian tumors.
    Lindgren PR; Bäckström T; Cajander S; Damber MG; Mählck CG; Zhu D; Olofsson JI
    Int J Oncol; 2002 Sep; 21(3):583-9. PubMed ID: 12168103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadal steroids, gonadotropins and endometrial histology in postmenopausal women with malignant ovarian tumors.
    Jeppsson S; Karlsson S; Kullander S
    Acta Obstet Gynecol Scand; 1986; 65(3):207-10. PubMed ID: 3090850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum thrombopoietin levels are higher in patients with ovarian cancer than with benign cysts.
    Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):67-70. PubMed ID: 16359773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.